SCID pig could test human therapies

SCID pig could test human therapies

Pigs with naturally occurring immunodeficiency could be used as model for testing regenerative medicine in people.

A GRANT of $2.5 million from the National Institutes of Health will fund Iowa State University research to develop a line of pigs with an immune system that is uniquely suited to testing medical therapies for people.

Four years ago, in work that originated at Iowa State, scientists identified the first pigs with naturally occurring severe combined immunodeficiency (SCID). Until this discovery, the inherited disorder was only known to naturally affe

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.